معرفی
Dr. Jessica Collins is a Research Fellow at the Wicking Dementia Research Education Centre, University of Tasmania. Her research focuses on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s, with an emphasis on biomarker development and early detection strategies. She leads projects involving blood-based biomarkers, smartphone-based diagnostic tools, and interdisciplinary clinical models to address dementia risk factors. Key collaborations include work with Royal Hobart Hospital, NHMRC, and international institutions.
Her supervision includes doctoral projects on pericyte dysfunction post-stroke, neurofilament proteins as biomarkers, and SARM1’s role in frontotemporal dementia. She has advised Ellie Annemarie Bucher, whose thesis addressed interneurons in aging and neurodegeneration. Dr. Collins’ grants span $3.7M+ in funding, targeting biomarker assays, clinical trial support, and remote screening technologies. Notable projects include developing blood tests for Parkinson’s and Alzheimer’s, and refining reaction-time analysis for dementia detection.
Her research outputs highlight innovative approaches like aptamer-based biosensors and smartphone screening, emphasizing accessibility and early intervention. The Wicking Centre’s interdisciplinary environment supports her translational work, aiming to bridge lab findings with clinical applications.
